
Conference Coverage
about 7 hours ago
How Do GLP-1 Agonists Fit Into Stroke Care?Latest Content

Real-World Evidence Backs Acalabrutinib in CLL Care

Is Less More After Thrombolysis? Debating Intensive Stroke Monitoring at ISC 2026

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

AJMC® in the Press, February 6, 2026

Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

Experts at ISC 2026 highlighted growing evidence that GLP-1 receptor agonists may reduce stroke risk and support brain health through anti-inflammatory, vascular, and neuroprotective mechanisms.

First announced in September 2025, the online platform is set to offer access to prescription medications at steep discounts, with potential savings in the millions.

Across 39 patients in 2 cohorts, rapid microbe reduction, high wound closure, restored warmth and sensation, and avoided amputations were observed.

OCEANIC-STROKE shows asundexian cuts ischemic stroke recurrence by 26% in patients taking standard antiplatelet therapy, with no major bleeding increase.

Cencora’s fast-tracked acquisition of OneOncology could boost community cancer care access and bring advanced therapies closer to patients.

A deep-learning serial CT response score outperformed conventional imaging measures in predicting OS for patients with advanced NSCLC treated with ICIs.

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin.

Experts propose a 6-parameter framework for ATTR-CM monitoring and disease progression in transthyretin amyloid cardiomyopathy.

Yearly dental visits were associated with fewer secondary strokes, and hyperthyroidism was flagged as a key CVST risk factor in women.

Shervin Badihian, MD, explains how digital health tools can help boost poststroke activity via reminders, goals, feedback, and gamification.


























